Faculty of Medicine and Health Technology

Activities

Activities per year 1994 2017 2018 2019 2025

• 838 Reviewer of Scientific Journal
• 774 Conference presentation
• 302 Reviewer of Conference Article
• 103 Invited lecture
• 802 More
  • 85 Public talk
  • 84 Visit abroad
  • 65 Pre-examination of dissertation or acting as opponent to doctoral students
  • 60 Media appearance
  • 55 Regular membership of a society or network
  • 53 Position of trust in public sector
  • 48 Membership of a scientific or program committee of a conference or seminar
  • 41 Chair of workshop, panel, session or tutorial
  • 33 Supervisor of master student
  • 32 Position of trust in an academic community
  • 31 Supervisor of doctoral candidate
  • 27 Membership of an editorial board
  • 25 Membership of an organizing committee of a conference or seminar
  • 25 Organization of a workshop, panel, session or tutorial
  • 17 Statement of assessment of docentship
  • 16 Supervisor of licentiate candidate in medicine
  • 13 Hosting a visitor
  • 12 Participant of a conference, workshop, panel, session or tutorial
  • 12 Supervisor of bachelor student
  • 10 Evaluation of funding applications
  • 8 Consultancy
  • 7 Statement of assessment of professorship
  • 6 Editorship of a book or a special issue of a journal
  • 6 Leadership of a scientific program or project
  • 5 Position of trust in the private sector
  • 4 Social media activity
  • 3 Evaluation of activities
  • 3 Position of trust in a funding organization
  • 3 Position of trust in a society or network
  • 3 Academic qualification (e.g. title of docent)
  • 2 Reviewer of Other Manuscript
  • 2 Statement of assessment of other positions
  • 2 Supervisor of licentiate candidate
  • 2 Granted research funding
  • 1 Membership of a jury
  • 1 Studies abroad

Activities per year

Search results

• Työhyvinvointi itseohjautuvissa organisaatiossa: kuormitustekijät, voimavarat ja työhyvinvoinnin edistäminen

  Larjovuori, R.-L. (Speaker), Heikkilä-Tammi, K. (Speaker), Kinnari, I. (Speaker) & Nieminen, H. (Speaker)

  10 Dec 2020

  Activity: Talk or presentation › Conference presentation

• Työhyvinvointi itseohjautuvissa organisaatiossa: kuormitustekijät, voimavarat ja työhyvinvoinnin edistäminen

  Larjovuori, R.-L. (Speaker), Heikkilä-Tammi, K. (Contributor), Kinnari, I. (Contributor) & Nieminen, H. (Contributor)

  10 Dec 2020

  Activity: Talk or presentation › Conference presentation

• Etäläheiset. Hoivakotien koronaeristys läheisten kokemana.

  Pirhonen, J. (Speaker), Blomqvist, K. (Contributor), Harju, M. (Contributor), Laakkonen, R. (Speaker), Lemivaara, M. (Speaker) & Pietilä, I. (Speaker)

  17 Nov 2020

  Activity: Talk or presentation › Conference presentation

• Long-term prognosis of patients with insulinoma

  Peltola, E. (Speaker), Hannula, P. (Contributor), Huhtala, H. (Contributor), Metso, S. (Contributor), Sand, J. (Contributor), Laukkarinen, J. (Contributor), Tiikkainen, M. (Contributor), Sirén, J. (Contributor), Soinio, M. (Contributor), Nuutila, P. (Contributor), Moilanen, L. (Contributor), Laaksonen, D. (Contributor), Ebeling, T. (Contributor), Arola, J. (Contributor), Schalin-Jäntti, C. (Contributor) & Jaatinen, P. (Contributor)

  30 Oct 2020

  Activity: Talk or presentation › Conference presentation

• Viewpoints in nursing professional´s eHealth competence in multidisciplinary practice

  Värri, A. (Speaker) & Ahonen, O. (Contributor)

  1 Oct 2020

  Activity: Talk or presentation › Conference presentation

  File

• Eturauhassyöpäpotilaiden kokemukset ohjatusta liikuntaharjoittelusta hormonihoidon aikana

  Harju, E. (Contributor), Murtola, T. (Contributor) & Ojala, H. (Contributor)

  30 Sept 2020

  Activity: Talk or presentation › Conference presentation

• Tolerability and treatment response to darolutamide (DARO) in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) in the phase 3 ARAMIS trial

  Tammela, T. (Contributor)

  17 Sept 2020

  Activity: Talk or presentation › Conference presentation

• Efficacy and safety of darolutamide (DARO) in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) and a prostate-specific antigen doubling time (PSADT) of >6 months

  Bögemann, M. (Contributor), Shore, N. (Contributor), Tammela, T. (Contributor), Ulys, A. (Contributor), Vjaters, E. (Contributor), Polyakov, S. (Contributor), Jievaltas, M. (Contributor), Luz, M. (Contributor), Alekseev, B. (Contributor), Kuss, I. (Contributor), Le Berre, M.-A. (Contributor), Snapir, A. (Contributor), Sarapohja, T. (Contributor) & Fizazi, K. (Contributor)

  17 Jul 2020

  Activity: Talk or presentation › Conference presentation

• Biophysical modeling of astrocytes and astrocyte-neuron interactions

  Manninen, T. (Speaker)

  13 Jul 2020

  Activity: Talk or presentation › Conference presentation

• Overall survival (OS) results of phase III ARAMIS study of darolutamide (DARO) added to androgen deprivation therapy (ADT) for nonmetastatic castration-resistant prostate cancer (nmCRPC)

  Fizazi, K. (Contributor), Shore, N. (Contributor), Tammela, T. (Contributor), Ulys, A. (Contributor), Vjaters, E. (Contributor), Polyakov, S. (Contributor), Jievaltas, M. (Contributor), Luz, M. (Contributor), Alekseev, B. (Contributor), Kuss, I. (Contributor), Le Berre, M.-A. (Contributor), Petrenciuc, O. (Contributor), Snapir, A. (Contributor), Sarapohja, T. (Contributor) & Smith, M. (Contributor)

  29 May 2020

  Activity: Talk or presentation › Conference presentation

• Assessing the clinical relevance of drug-drug interactions (DDI) with darolutamide (DARO)

  Tammela, T. (Speaker)

  14 May 2020

  Activity: Talk or presentation › Conference presentation

• Parent-led training for motivating eye contact in children with autism spectrum disorder: BOSCC outcome study.

  Husu, E. (Speaker), Muuvila, M. (Contributor), Helminen, T. (Contributor), Ahonen, S. (Contributor), Lauttia, J. (Contributor), Eriksson, K. (Contributor) & Kylliäinen, A. (Contributor)

  6 May 2020 → 9 May 2020

  Activity: Talk or presentation › Conference presentation

• The inflammatory regulation of TRPA1 expression in human A549 lung epithelial cells

  Luostarinen, S. (Contributor), Hämäläinen, M. (Contributor), Hatano, N. (Contributor), Muraki, K. (Contributor) & Moilanen, E. (Contributor)

  13 Feb 2020

  Activity: Talk or presentation › Conference presentation

• Anti-Inflammatory and anti-catabolic effects of dexamethasone are mediated through MKP-1 in murine models

  Myyry, T. (Contributor), Leppänen, T. (Contributor), Nieminen, R. (Contributor), Tuure, L. (Contributor) & Moilanen, E. (Contributor)

  13 Feb 2020

  Activity: Talk or presentation › Conference presentation

• Celiac Disease: Future Therapies

  Mäki, M. (Speaker)

  30 Jan 2020

  Activity: Talk or presentation › Conference presentation

• Celiac Disease: the new ESPGHAN guidelines

  Mäki, M. (Speaker)

  29 Jan 2020

  Activity: Talk or presentation › Conference presentation

• Celiac Disease: dilemmas in diagnosis and management

  Mäki, M. (Speaker)

  29 Jan 2020

  Activity: Talk or presentation › Conference presentation

• Annual review of health informatics standardisation 2019

  Värri, A. (Speaker)

  16 Dec 2019

  Activity: Talk or presentation › Conference presentation

• SoWell-tutkimus ja osallistava tutkimusote

  Pirhonen, J. (Speaker), Tuominen, K. (Contributor), Jolanki, O. (Contributor) & Jylhä, M. (Contributor)

  9 Dec 2019

  Activity: Talk or presentation › Conference presentation

• Future treatments of celiac disease

  Kurppa, K. (Speaker)

  6 Dec 2019

  Activity: Talk or presentation › Conference presentation

• Guidance of human pluripotent stem cell -derived neurons in microfluidics device using light-responsive polymer

  Ristola, M. (Contributor), Hyvärinen, T. (Contributor) & Narkilahti, S. (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Double collagen-coated honeycomb films supporting co-culture of hiPSC-derived cells: an in vitro model of the blood-retinal barrier

  Åkerman, H. (Contributor), Aalto-Setälä, K. (Contributor), Juuti-Uusitalo, K. (Contributor), Miettinen, S. (Contributor) & Skottman, H. (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• HLA-DQ2 dose effect on clinical picture of celiac disease

  Airaksinen, L. (Contributor), Laurikka, P. (Contributor), Pekki, H. (Contributor), Kurppa, K. (Contributor), Huhtala, H. (Contributor), Saavalainen, P. (Contributor), Kaukinen, K. (Contributor) & Lindfors, K. (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Effects of a selective inhibitor of inducible prostaglandin E synthase-1 (mPGES-1) in human OA chondrocytes: RNA-Seq-based study

  Tuure, L. (Contributor), Pemmari, A. (Contributor), Hämäläinen, M. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Independent and cumulative effects of celiac disease susceptibility loci differentially contribute to various clinical phenotypes

  Xavier de Miranda Cerqueira, J. (Contributor), Kaukinen, K. (Contributor) & Lindfors, K. (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Celiac disease and inflammatory bowel disease in patients with IgA nephropathy over time

  Pörsti, I. (Contributor), Huhtala, H. (Contributor), Kaukinen, K. (Contributor), Mustonen, J. (Contributor), Mäkelä, S. (Contributor) & Niemelä, O. (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Presentation

  Hagman, S. (Speaker)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Anti-inflammatory and anti-catabolic effects of dexamethasone are mediated through MKP-1 in murine models

  Leppänen, T. (Contributor), Moilanen, E. (Contributor) & Nieminen, R. (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq

  Hämäläinen, M. (Contributor), Leppänen, T. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) mediates FGF-2 expression in chondrocytes

  Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Pemmari, A. (Contributor), Moilanen, E. (Contributor), Moilanen, L. (Contributor), Nieminen, R. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, T. (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Anti-inflammatory mechanisms of PDE4 inhibitors: Rolipram induces macrophage polarization from inflammatory (M1) to healing promoting (M2) phenotype through MKP-1

  Leppänen, T. (Contributor), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor) & Nieminen, R. (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• The inflammatory regulation of transient receptor potential ankyrin-1 gene expression in human A549 lung epithelial cells

  Luostarinen, S. (Contributor), Hämäläinen, S. (Contributor), Hatano, M. (Contributor), Muraki, N. (Contributor) & Moilanen, K. (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Differences in clinical features of celiac disease between children and adults

  Koskimaa, S. (Contributor), Kivelä, L. (Contributor), Kröger, S. (Contributor), Salmi, T. (Contributor), Kaukinen, K. (Contributor) & Kurppa, K. (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• TRPA1 mediates DNCB-induced allergic contact dermatitis

  Mäki-Opas, I. (Contributor), Hämäläinen, M. (Contributor), Moilanen, L. (Contributor), Sood, H. (Contributor), Leppänen, T. (Contributor), Lehtimäki, L. (Contributor) & Moilanen, E. (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Changing face of type 1 tyrosinemia in Finland

  Aitokari, L. (Contributor), Hiltunen, P. (Contributor), Soini, T. (Contributor), Kivelä, L. (Contributor), Heikinheimo, M. (Contributor) & Kurppa, K. (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Efficacy and safety of darolutamide in non-metastatic castration-resistant prostate cancer (nmCRPC) in the ARAMIS trial

  Tammela, T. (Contributor)

  23 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Työterveyshuollon sairaanhoidon suurkuluttajat ja työkyvyttömyys

  Reho, T. (Speaker)

  21 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Intraprostatic injection of Liproca® Depot (2-hydroxy flutamide) in patient with localised prostate cancer

  Tammela, T. (Contributor)

  16 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Työterveyshuollon sairaanhoidon suurkuluttajat ja työkyvyttömyys

  Reho, T. (Speaker)

  25 Oct 2019

  Activity: Talk or presentation › Conference presentation

• Increased seroreactivity to microbial markers in first-degree relatives of celiac disease patients

  Huhtala, H. (Contributor), Kaukinen, K. (Contributor), Kurppa, K. (Contributor) & Lindfors, K. (Contributor)

  23 Oct 2019

  Activity: Talk or presentation › Conference presentation

• Development of Nanostructured Alginate-Gelatin -Based Inks for 3D Bioprinting of Bone Cells

  Paulamäki, J. (Speaker), Rashad, A. (Contributor), Karvinen, J. (Contributor), Koivisto, J. (Contributor), Kellomäki, M. (Contributor), Syverud, K. (Contributor), Miettinen, S. (Contributor) & Mustafa, K. (Contributor)

  20 Oct 2019

  Activity: Talk or presentation › Conference presentation

• Upper gastrointestinal tract findings in pediatric IBD: prevalence and association with other disease features

  Repo, M. (Contributor), Pessi, J. (Contributor), Wirtanen, E. (Contributor), Hiltunen, P. (Contributor), Ruuska, T. (Contributor), Kuivasmäki, L. (Contributor) & Kurppa, K. (Contributor)

  20 Oct 2019

  Activity: Talk or presentation › Conference presentation

• Simultaneous and sequential immunization schedules of multivalent norovirus VLPs differ for induction of protective immune responses to norovirus

  Malm, M. (Contributor) & Blazevic, V. (Contributor)

  14 Oct 2019

  Activity: Talk or presentation › Conference presentation

• Norovirus T cell responses in children and adults

  Tamminen, K. (Contributor)

  14 Oct 2019

  Activity: Talk or presentation › Conference presentation

• Norovirus-like particles as a foreign antigen delivery platform

  Heinimäki, S. (Contributor), Blazevic, V. (Contributor), Hytönen, V. (Contributor) & Lampinen, V. (Contributor)

  14 Oct 2019

  Activity: Talk or presentation › Conference presentation

• Presentation

  Hagman, S. (Contributor), Hyvärinen, T. (Contributor), Ristola, M. (Contributor), Sukki, L. (Contributor), Veijula, K. (Contributor), Kreutzer, J. (Contributor), Kallio, P. (Contributor) & Narkilahti, S. (Contributor)

  11 Oct 2019

  Activity: Talk or presentation › Conference presentation

• Guidance of human pluripotent stem cell -derived neurons in microfluidics device using light-responsive polymer

  Ristola, M. (Contributor), Fedele, C. (Contributor), Sukki, L. (Contributor), Hyvärinen, T. (Contributor), Priimägi, A. (Contributor), Kallio, P. (Contributor) & Narkilahti, S. (Contributor)

  11 Oct 2019

  Activity: Talk or presentation › Conference presentation

• Experiences of supervised resistance exercise in prostate cancer patients undergoing androgen deprivation therapy - a pilot study

  Harju, E. (Speaker), Hakulinen, A. (Speaker), Hakulinen, A. (Speaker), Ojala, H. (Speaker) & Murtola, T. (Speaker)

  3 Oct 2019

  Activity: Talk or presentation › Conference presentation

• YKL-40, IL-8 and IL-6 in clusters of adult-onset asthma

  Ilmarinen, P. (Contributor), Tuomisto, L. (Contributor), Niemelä, O. (Contributor), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor) & Kankaanranta, H. (Contributor)

  28 Sept 2019

  Activity: Talk or presentation › Conference presentation

• The hunt for adjunctive or alternative therapies for coeliac disease. (Quali terapie nuove o supplementari per la celiachia)

  Mäki, M. (Speaker)

  27 Sept 2019

  Activity: Talk or presentation › Conference presentation